Based on 82 Wall Street analysts offering 12 month price targets to BNY Mellon Small/Mid Cap Growth Fund Class I holdings in the last 3 months. The average price target is $36.02 with a high forecast of $43.19 and a low forecast of $28.52. The average price target represents a 16.79% change from the last price of $30.84.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"24":"$24","29":"$29","34":"$34","39":"$39","44":"$44"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":43.192,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$43.19</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.018,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$36.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28.523,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$28.52</span>\n  </div></div>","useHTML":true}}],"tickPositions":[24,29,34,39,44],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2024","6":"Jul<br/>2024","9":"Oct<br/>2024","12":"Jan<br/>2025","25":"Jan<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.01,30.100923076923078,31.191846153846157,32.28276923076923,33.37369230769231,34.464615384615385,35.55553846153846,36.64646153846154,37.73738461538461,38.82830769230769,39.91923076923077,41.01015384615385,42.101076923076924,{"y":43.192,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.01,29.549076923076925,30.088153846153848,30.62723076923077,31.166307692307694,31.705384615384617,32.244461538461536,32.78353846153846,33.32261538461539,33.86169230769231,34.40076923076923,34.939846153846155,35.47892307692308,{"y":36.018,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.01,28.972538461538463,28.935076923076924,28.897615384615385,28.860153846153846,28.822692307692307,28.78523076923077,28.747769230769233,28.710307692307694,28.672846153846155,28.635384615384616,28.597923076923077,28.56046153846154,{"y":28.523,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":25.83,"date":1704153600000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.78,"date":1706745600000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.82,"date":1709251200000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.83,"date":1711929600000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.54,"date":1714521600000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.7,"date":1717372800000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.88,"date":1719792000000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.43,"date":1722470400000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.32,"date":1725321600000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.53,"date":1727740800000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.95,"date":1730419200000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":30.41,"date":1733097600000,"info":"<div>Price: <b>$30<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.01,"date":1735776000000,"info":"<div>Price: <b>$29<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$43.19

Average Price Target$36.02

Lowest Price Target$28.52

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SDSCX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

AUTL

Autolus Therapeutics

7 Buy

0 Hold

0 Sell

Strong Buy

$10.32

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RARE

Ultragenyx Pharmaceutical, Inc.

17 Buy

1 Hold

0 Sell

Strong Buy

$88.87

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PACB

Pacific Biosciences

4 Buy

5 Hold

0 Sell

Moderate Buy

$2.92

xxxxxxxxxxxxxxxxxxxxxxxxxxx

DNLI

Denali Therapeutics

14 Buy

0 Hold

0 Sell

Strong Buy

$40.77

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SRPT

Sarepta Therapeutics Inc.

18 Buy

0 Hold

1 Sell

Strong Buy

$181.75

SDSCX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GRAL

Grail Inc

0 Buy

2 Hold

0 Sell

Hold

$16.00

xxxxxxxxxxxxxxxxxxxxxxxxxxx

WRBY

Warby Parker, Inc. Class A

8 Buy

6 Hold

0 Sell

Moderate Buy

$24.08

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RDDT

Reddit, Inc. Class A

11 Buy

5 Hold

1 Sell

Moderate Buy

$180.76

xxxxxxxxxxxxxxxxxxxxxxxxxxx

Guardant Health

18 Buy

0 Hold

0 Sell

Strong Buy

$43.73

xxxxxxxxxxxxxxxxxxxxxxxxxxx

IRTC

Irhythm Technologies

9 Buy

2 Hold

0 Sell

Strong Buy

$106.50

SDSCX Mutual Fund FAQ

What is SDSCX’s average 12-month price target, according to analysts?

Based on analyst ratings, BNY Mellon Small/Mid Cap Growth Fund Class I’s 12-month average price target is $36.02.

What is SDSCX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for SDSCX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SDSCX a Buy, Sell or Hold?

BNY Mellon Small/Mid Cap Growth Fund Class I has a consensus rating of Moderate Buy which is based on 67 buy ratings, 14 hold ratings and 1 sell ratings.

What is BNY Mellon Small/Mid Cap Growth Fund Class I’s price target?

The average price target for BNY Mellon Small/Mid Cap Growth Fund Class I is $36.02. This is based on 82 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $43.19 ,the lowest forecast is $28.52. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about BNY Mellon Small/Mid Cap Growth Fund Class I?

BNY Mellon Small/Mid Cap Growth Fund Class I’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 82 Wall Streets Analysts.

How can I buy shares of SDSCX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing